18 June 2013
Keywords: reolysin, fares, well, early, carcinoma, trial, biotechnology
Article | 21 April 2008
US biotechnology firm Oncolytics Biotech has reported positive interim results from a UK carcinoma trial assessing carboplatin and paclitaxel
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 April 2008
14 April 2008
28 April 2008
© 2013 thepharmaletter.com